Mina Nakagawa

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Binding Protein

Hepatitis C Virus

Top Venues

Journal of gastroenterology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Keiya Watakabe, Masato Miyoshi, Sei Kakinuma, Ayako Sato, Jun Tsuchiya, Taro Shimizu, Tomohiro Mochida, Kento Inada, Shun Kaneko, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Mina Nakagawa, Shigeru Oshima, Mamoru Watanabe, Averil Ma, Yasuhiro Asahina, Ryuichi Okamoto
A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1-JNK pathway-dependent chemokines. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (13) (2024)
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto
Correction: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of gastroenterology (2023)
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto
Correction: Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of gastroenterology (2023)
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of gastroenterology (2022)
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of gastroenterology (2022)
Mina Nakagawa, Yasuhiro Asahina, Sei Kakinuma, Ryuichi Okamoto
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR. Journal of gastroenterology (2022)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Mina Nakagawa, Nobutoshi Nawa, Eiko Takeichi, Taro Shimizu, Jun Tsuchiya, Ayako Sato, Masato Miyoshi, Fukiko Kawai-Kitahata, Miyako Murakawa, Sayuri Nitta, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma, Takeo Fujiwara, Mamoru Watanabe, Yujiro Tanaka, Yasuhiro Asahina, null null
Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs. Journal of gastroenterology 55 (10) (2020)